Hyperfine director granted 157,700 stock options
Hyperfine, Inc. director John T. Dahldorf received a grant of stock options to buy 157,700 shares of Class A common stock at an exercise price of $1.49 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hyperfine, Inc. director John T. Dahldorf received a grant of stock options to buy 157,700 shares of Class A common stock at an exercise price of $1.49 per share. The options expire on May 22, 2036 and vest at the issuer's next regular annual stockholders meeting, subject to his continued service. Following this award, he holds 157,700 options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) | 157,700 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.
Key Figures
Key Terms
Stock Options (right to buy) financial
Class A Common Stock financial
exercise price financial
vesting financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Hyperfine (HYPR) director John T. Dahldorf report on this Form 4?
How many Hyperfine (HYPR) stock options were granted to John T. Dahldorf?
What is the exercise price of John T. Dahldorf’s Hyperfine (HYPR) options?
When do John T. Dahldorf’s Hyperfine (HYPR) stock options vest?
When do John T. Dahldorf’s Hyperfine (HYPR) options expire?
Is John T. Dahldorf’s Hyperfine (HYPR) transaction an open-market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.